227 related articles for article (PubMed ID: 17646634)
21. Genotype-phenotype correlation in vanishing white matter disease.
van der Lei HD; van Berkel CG; van Wieringen WN; Brenner C; Feigenbaum A; Mercimek-Mahmutoglu S; Philippart M; Tatli B; Wassmer E; Scheper GC; van der Knaap MS
Neurology; 2010 Oct; 75(17):1555-9. PubMed ID: 20975056
[TBL] [Abstract][Full Text] [Related]
22. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor.
Peter L; Niel F; Catenoix H; Jung J; Demarquay G; Petiot P; Rudigoz RC; Boespflug-Tanguy O; Ryvlin P; Mauguière F
Eur J Neurol; 2008 Jan; 15(1):94-7. PubMed ID: 18005052
[TBL] [Abstract][Full Text] [Related]
23. Identification of ten novel mutations in patients with eIF2B-related disorders.
Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
[TBL] [Abstract][Full Text] [Related]
24. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
[TBL] [Abstract][Full Text] [Related]
25. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination.
Wolf NI; Harting I; Boltshauser E; Wiegand G; Koch MJ; Schmitt-Mechelke T; Martin E; Zschocke J; Uhlenberg B; Hoffmann GF; Weber L; Ebinger F; Rating D
Neurology; 2005 Apr; 64(8):1461-4. PubMed ID: 15851747
[TBL] [Abstract][Full Text] [Related]
26. The latest on leukodystrophies.
Schiffmann R; van der Knaap MS
Curr Opin Neurol; 2004 Apr; 17(2):187-92. PubMed ID: 15021247
[TBL] [Abstract][Full Text] [Related]
27. Expansion of the deletion 13q syndrome phenotype: a case report.
Lance EI; DuPont BR; Holden KR
J Child Neurol; 2007 Sep; 22(9):1124-7. PubMed ID: 17890413
[TBL] [Abstract][Full Text] [Related]
28. Location and type of mutation in the LIS1 gene do not predict phenotypic severity.
Uyanik G; Morris-Rosendahl DJ; Stiegler J; Klapecki J; Gross C; Berman Y; Martin P; Dey L; Spranger S; Korenke GC; Schreyer I; Hertzberg C; Neumann TE; Burkart P; Spaich C; Meng M; Holthausen H; Adès L; Seidel J; Mangold E; Buyse G; Meinecke P; Schara U; Zeschnigk C; Muller D; Helland G; Schulze B; Wright ML; Kortge-Jung S; Hehr A; Bogdahn U; Schuierer G; Kohlhase J; Aigner L; Wolff G; Hehr U; Winkler J
Neurology; 2007 Jul; 69(5):442-7. PubMed ID: 17664403
[TBL] [Abstract][Full Text] [Related]
29. X-linked oligophrenic vermian dysgenesis: syndromic vs non-syndromic X-linked mental retardation?
Higgins JJ; Topaloglu H
Neurology; 2005 Nov; 65(9):1346-7. PubMed ID: 16275817
[No Abstract] [Full Text] [Related]
30. Smooth mosaics: genotype and phenotype in lissencephaly.
Jung HH
Neurology; 2007 Jul; 69(5):425-6. PubMed ID: 17664400
[No Abstract] [Full Text] [Related]
31. Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth Disease.
Kassubek J; Bretschneider V; Sperfeld AD
J Clin Neurosci; 2005 Jun; 12(5):588-9. PubMed ID: 16051098
[TBL] [Abstract][Full Text] [Related]
32. Where has all the white matter gone? Unraveling the mysteries of leukoencephalopathies.
Kaye EM; Moser H
Neurology; 2004 May; 62(9):1464-5. PubMed ID: 15136665
[No Abstract] [Full Text] [Related]
33. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.
Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T
Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694
[TBL] [Abstract][Full Text] [Related]
34. Peripheral neuropathy in a child with Cree leukodystrophy.
Huntsman RJ; Seshia S; Lowry N; Lemire EG; Harder SL
J Child Neurol; 2007 Jun; 22(6):766-8. PubMed ID: 17641267
[TBL] [Abstract][Full Text] [Related]
35. Genetic and clinical heterogeneity in eIF2B-related disorder.
Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
[TBL] [Abstract][Full Text] [Related]
36. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy.
Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F
Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750
[TBL] [Abstract][Full Text] [Related]
37. [eIF2B and Cree Indian leukodystrophies].
Fogli A; Rodriguez D; Eymard-Pierre E; Boespflug-Tanguy O
Med Sci (Paris); 2003 Mar; 19(3):283-4. PubMed ID: 12836410
[No Abstract] [Full Text] [Related]
38. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.
Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K
Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic variability in giant axonal neuropathy.
Tazir M; Nouioua S; Magy L; Huehne K; Assami S; Urtizberea A; Grid D; Hamadouche T; Rautenstrauss B; Vallat JM
Neuromuscul Disord; 2009 Apr; 19(4):270-4. PubMed ID: 19231187
[TBL] [Abstract][Full Text] [Related]
40. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
